nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—CYP3A4—Temozolomide—brain cancer	0.3	0.486	CbGbCtD
Rifaximin—CYP3A4—Lomustine—brain cancer	0.255	0.414	CbGbCtD
Rifaximin—CYP3A4—Etoposide—brain cancer	0.0617	0.1	CbGbCtD
Rifaximin—Rifapentine—CYP2C9—brain cancer	0.00888	0.616	CrCbGaD
Rifaximin—Rifampicin—CYP2C9—brain cancer	0.00554	0.384	CrCbGaD
Rifaximin—Epistaxis—Procarbazine—brain cancer	0.00231	0.00626	CcSEcCtD
Rifaximin—Ear pain—Temozolomide—brain cancer	0.00225	0.00611	CcSEcCtD
Rifaximin—Body temperature increased—Carboplatin—brain cancer	0.00222	0.00603	CcSEcCtD
Rifaximin—Haemoglobin—Procarbazine—brain cancer	0.00221	0.00599	CcSEcCtD
Rifaximin—Haemorrhage—Procarbazine—brain cancer	0.0022	0.00596	CcSEcCtD
Rifaximin—Decreased appetite—Lomustine—brain cancer	0.00214	0.0058	CcSEcCtD
Rifaximin—Amnesia—Carmustine—brain cancer	0.00211	0.00574	CcSEcCtD
Rifaximin—Hot flush—Temozolomide—brain cancer	0.00205	0.00557	CcSEcCtD
Rifaximin—Amnesia—Temozolomide—brain cancer	0.00204	0.00555	CcSEcCtD
Rifaximin—Flushing—Procarbazine—brain cancer	0.00204	0.00553	CcSEcCtD
Rifaximin—Menopausal symptoms—Temozolomide—brain cancer	0.00203	0.00552	CcSEcCtD
Rifaximin—Dermatitis exfoliative—Temozolomide—brain cancer	0.00203	0.00552	CcSEcCtD
Rifaximin—Hyponatraemia—Carmustine—brain cancer	0.00199	0.00541	CcSEcCtD
Rifaximin—Dysuria—Hydroxyurea—brain cancer	0.00199	0.00539	CcSEcCtD
Rifaximin—Neutropenia—Hydroxyurea—brain cancer	0.00199	0.00539	CcSEcCtD
Rifaximin—Body temperature increased—Lomustine—brain cancer	0.00194	0.00527	CcSEcCtD
Rifaximin—Weight increased—Hydroxyurea—brain cancer	0.00193	0.00525	CcSEcCtD
Rifaximin—Infestation NOS—Hydroxyurea—brain cancer	0.00189	0.00514	CcSEcCtD
Rifaximin—Infestation—Hydroxyurea—brain cancer	0.00189	0.00514	CcSEcCtD
Rifaximin—Tremor—Procarbazine—brain cancer	0.00179	0.00486	CcSEcCtD
Rifaximin—Dehydration—Temozolomide—brain cancer	0.00179	0.00485	CcSEcCtD
Rifaximin—Anaemia—Procarbazine—brain cancer	0.00177	0.0048	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00173	0.00469	CcSEcCtD
Rifaximin—Dysphagia—Carmustine—brain cancer	0.00172	0.00466	CcSEcCtD
Rifaximin—Syncope—Procarbazine—brain cancer	0.00172	0.00465	CcSEcCtD
Rifaximin—Haemoglobin—Hydroxyurea—brain cancer	0.00171	0.00464	CcSEcCtD
Rifaximin—Haemorrhage—Hydroxyurea—brain cancer	0.0017	0.00461	CcSEcCtD
Rifaximin—Loss of consciousness—Procarbazine—brain cancer	0.00168	0.00456	CcSEcCtD
Rifaximin—Abdominal distension—Temozolomide—brain cancer	0.00167	0.00453	CcSEcCtD
Rifaximin—Cough—Procarbazine—brain cancer	0.00167	0.00453	CcSEcCtD
Rifaximin—Dysphagia—Temozolomide—brain cancer	0.00166	0.0045	CcSEcCtD
Rifaximin—Myalgia—Procarbazine—brain cancer	0.00163	0.00442	CcSEcCtD
Rifaximin—Arthralgia—Procarbazine—brain cancer	0.00163	0.00442	CcSEcCtD
Rifaximin—Sweating increased—Temozolomide—brain cancer	0.00162	0.00439	CcSEcCtD
Rifaximin—Neutropenia—Carmustine—brain cancer	0.00161	0.00436	CcSEcCtD
Rifaximin—Dry mouth—Procarbazine—brain cancer	0.00159	0.00432	CcSEcCtD
Rifaximin—Confusional state—Procarbazine—brain cancer	0.00157	0.00427	CcSEcCtD
Rifaximin—Vomiting—Lomustine—brain cancer	0.00156	0.00424	CcSEcCtD
Rifaximin—Dysuria—Temozolomide—brain cancer	0.00155	0.00421	CcSEcCtD
Rifaximin—Neutropenia—Temozolomide—brain cancer	0.00155	0.00421	CcSEcCtD
Rifaximin—Infection—Procarbazine—brain cancer	0.00155	0.00421	CcSEcCtD
Rifaximin—Hyperglycaemia—Carmustine—brain cancer	0.00155	0.0042	CcSEcCtD
Rifaximin—Angiopathy—Hydroxyurea—brain cancer	0.00154	0.00419	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Temozolomide—brain cancer	0.00154	0.00419	CcSEcCtD
Rifaximin—Pneumonia—Carmustine—brain cancer	0.00154	0.00418	CcSEcCtD
Rifaximin—Shock—Procarbazine—brain cancer	0.00154	0.00417	CcSEcCtD
Rifaximin—Pollakiuria—Temozolomide—brain cancer	0.00153	0.00416	CcSEcCtD
Rifaximin—Depression—Carmustine—brain cancer	0.00153	0.00414	CcSEcCtD
Rifaximin—Photosensitivity reaction—Temozolomide—brain cancer	0.00151	0.00411	CcSEcCtD
Rifaximin—Weight increased—Temozolomide—brain cancer	0.00151	0.0041	CcSEcCtD
Rifaximin—Hyperhidrosis—Procarbazine—brain cancer	0.00151	0.0041	CcSEcCtD
Rifaximin—Weight decreased—Temozolomide—brain cancer	0.0015	0.00407	CcSEcCtD
Rifaximin—Hyperglycaemia—Temozolomide—brain cancer	0.0015	0.00406	CcSEcCtD
Rifaximin—Pneumonia—Temozolomide—brain cancer	0.00149	0.00404	CcSEcCtD
Rifaximin—Anorexia—Procarbazine—brain cancer	0.00149	0.00404	CcSEcCtD
Rifaximin—Infestation NOS—Temozolomide—brain cancer	0.00148	0.00402	CcSEcCtD
Rifaximin—Infestation—Temozolomide—brain cancer	0.00148	0.00402	CcSEcCtD
Rifaximin—Depression—Temozolomide—brain cancer	0.00148	0.004	CcSEcCtD
Rifaximin—Nausea—Lomustine—brain cancer	0.00146	0.00396	CcSEcCtD
Rifaximin—Hypotension—Procarbazine—brain cancer	0.00146	0.00396	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00142	0.00386	CcSEcCtD
Rifaximin—Insomnia—Procarbazine—brain cancer	0.00141	0.00383	CcSEcCtD
Rifaximin—Haemoglobin—Carmustine—brain cancer	0.00138	0.00375	CcSEcCtD
Rifaximin—Haemorrhage—Carmustine—brain cancer	0.00137	0.00373	CcSEcCtD
Rifaximin—Ill-defined disorder—Hydroxyurea—brain cancer	0.00137	0.00373	CcSEcCtD
Rifaximin—Anaemia—Hydroxyurea—brain cancer	0.00137	0.00371	CcSEcCtD
Rifaximin—Hypoaesthesia—Carmustine—brain cancer	0.00137	0.00371	CcSEcCtD
Rifaximin—Decreased appetite—Procarbazine—brain cancer	0.00136	0.00368	CcSEcCtD
Rifaximin—Oedema peripheral—Carmustine—brain cancer	0.00135	0.00367	CcSEcCtD
Rifaximin—Fatigue—Procarbazine—brain cancer	0.00135	0.00365	CcSEcCtD
Rifaximin—Haemoglobin—Temozolomide—brain cancer	0.00134	0.00362	CcSEcCtD
Rifaximin—Malaise—Hydroxyurea—brain cancer	0.00133	0.00362	CcSEcCtD
Rifaximin—Pain—Procarbazine—brain cancer	0.00133	0.00362	CcSEcCtD
Rifaximin—Constipation—Procarbazine—brain cancer	0.00133	0.00362	CcSEcCtD
Rifaximin—Haemorrhage—Temozolomide—brain cancer	0.00133	0.00361	CcSEcCtD
Rifaximin—Dysphagia—Etoposide—brain cancer	0.00133	0.0036	CcSEcCtD
Rifaximin—Hypoaesthesia—Temozolomide—brain cancer	0.00132	0.00359	CcSEcCtD
Rifaximin—Pharyngitis—Temozolomide—brain cancer	0.00132	0.00358	CcSEcCtD
Rifaximin—Urinary tract disorder—Temozolomide—brain cancer	0.00131	0.00356	CcSEcCtD
Rifaximin—Oedema peripheral—Temozolomide—brain cancer	0.00131	0.00355	CcSEcCtD
Rifaximin—Urethral disorder—Temozolomide—brain cancer	0.0013	0.00353	CcSEcCtD
Rifaximin—Sweating increased—Etoposide—brain cancer	0.00129	0.00351	CcSEcCtD
Rifaximin—Feeling abnormal—Procarbazine—brain cancer	0.00129	0.00349	CcSEcCtD
Rifaximin—Gastrointestinal pain—Procarbazine—brain cancer	0.00128	0.00346	CcSEcCtD
Rifaximin—Flushing—Carmustine—brain cancer	0.00128	0.00346	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00125	0.0034	CcSEcCtD
Rifaximin—Discomfort—Hydroxyurea—brain cancer	0.00125	0.00338	CcSEcCtD
Rifaximin—Neutropenia—Etoposide—brain cancer	0.00124	0.00337	CcSEcCtD
Rifaximin—Urticaria—Procarbazine—brain cancer	0.00124	0.00337	CcSEcCtD
Rifaximin—Tinnitus—Temozolomide—brain cancer	0.00124	0.00336	CcSEcCtD
Rifaximin—Abdominal pain—Procarbazine—brain cancer	0.00123	0.00335	CcSEcCtD
Rifaximin—Body temperature increased—Procarbazine—brain cancer	0.00123	0.00335	CcSEcCtD
Rifaximin—Flushing—Temozolomide—brain cancer	0.00123	0.00335	CcSEcCtD
Rifaximin—Angiopathy—Temozolomide—brain cancer	0.00121	0.00327	CcSEcCtD
Rifaximin—Mental disorder—Carmustine—brain cancer	0.0012	0.00327	CcSEcCtD
Rifaximin—Infection—Hydroxyurea—brain cancer	0.0012	0.00326	CcSEcCtD
Rifaximin—Mediastinal disorder—Temozolomide—brain cancer	0.0012	0.00325	CcSEcCtD
Rifaximin—Malnutrition—Carmustine—brain cancer	0.0012	0.00325	CcSEcCtD
Rifaximin—Pneumonia—Etoposide—brain cancer	0.00119	0.00323	CcSEcCtD
Rifaximin—Nervous system disorder—Hydroxyurea—brain cancer	0.00118	0.00322	CcSEcCtD
Rifaximin—Infestation NOS—Etoposide—brain cancer	0.00118	0.00321	CcSEcCtD
Rifaximin—Infestation—Etoposide—brain cancer	0.00118	0.00321	CcSEcCtD
Rifaximin—Skin disorder—Hydroxyurea—brain cancer	0.00117	0.00318	CcSEcCtD
Rifaximin—Mental disorder—Temozolomide—brain cancer	0.00116	0.00316	CcSEcCtD
Rifaximin—Back pain—Carmustine—brain cancer	0.00116	0.00314	CcSEcCtD
Rifaximin—Malnutrition—Temozolomide—brain cancer	0.00116	0.00314	CcSEcCtD
Rifaximin—Anorexia—Hydroxyurea—brain cancer	0.00115	0.00313	CcSEcCtD
Rifaximin—Hypersensitivity—Procarbazine—brain cancer	0.00115	0.00312	CcSEcCtD
Rifaximin—Tremor—Carmustine—brain cancer	0.00112	0.00304	CcSEcCtD
Rifaximin—Asthenia—Procarbazine—brain cancer	0.00112	0.00304	CcSEcCtD
Rifaximin—Back pain—Temozolomide—brain cancer	0.00112	0.00304	CcSEcCtD
Rifaximin—Anaemia—Carmustine—brain cancer	0.00111	0.003	CcSEcCtD
Rifaximin—Pruritus—Procarbazine—brain cancer	0.0011	0.003	CcSEcCtD
Rifaximin—Tremor—Temozolomide—brain cancer	0.00108	0.00294	CcSEcCtD
Rifaximin—Dyspnoea—Hydroxyurea—brain cancer	0.00108	0.00292	CcSEcCtD
Rifaximin—Ill-defined disorder—Temozolomide—brain cancer	0.00107	0.00291	CcSEcCtD
Rifaximin—Anaemia—Temozolomide—brain cancer	0.00107	0.0029	CcSEcCtD
Rifaximin—Diarrhoea—Procarbazine—brain cancer	0.00107	0.0029	CcSEcCtD
Rifaximin—Hypoaesthesia—Etoposide—brain cancer	0.00106	0.00287	CcSEcCtD
Rifaximin—Angioedema—Temozolomide—brain cancer	0.00106	0.00287	CcSEcCtD
Rifaximin—Decreased appetite—Hydroxyurea—brain cancer	0.00105	0.00285	CcSEcCtD
Rifaximin—Urinary tract disorder—Etoposide—brain cancer	0.00105	0.00285	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00104	0.00283	CcSEcCtD
Rifaximin—Malaise—Temozolomide—brain cancer	0.00104	0.00283	CcSEcCtD
Rifaximin—Urethral disorder—Etoposide—brain cancer	0.00104	0.00283	CcSEcCtD
Rifaximin—Fatigue—Hydroxyurea—brain cancer	0.00104	0.00283	CcSEcCtD
Rifaximin—Vertigo—Temozolomide—brain cancer	0.00104	0.00282	CcSEcCtD
Rifaximin—Pain—Hydroxyurea—brain cancer	0.00103	0.0028	CcSEcCtD
Rifaximin—Constipation—Hydroxyurea—brain cancer	0.00103	0.0028	CcSEcCtD
Rifaximin—Dizziness—Procarbazine—brain cancer	0.00103	0.0028	CcSEcCtD
Rifaximin—Chest pain—Carmustine—brain cancer	0.00102	0.00276	CcSEcCtD
Rifaximin—Myalgia—Carmustine—brain cancer	0.00102	0.00276	CcSEcCtD
Rifaximin—Cough—Temozolomide—brain cancer	0.00101	0.00274	CcSEcCtD
Rifaximin—Feeling abnormal—Hydroxyurea—brain cancer	0.000995	0.0027	CcSEcCtD
Rifaximin—Vomiting—Procarbazine—brain cancer	0.000992	0.00269	CcSEcCtD
Rifaximin—Flushing—Etoposide—brain cancer	0.000986	0.00268	CcSEcCtD
Rifaximin—Confusional state—Carmustine—brain cancer	0.000985	0.00267	CcSEcCtD
Rifaximin—Myalgia—Temozolomide—brain cancer	0.000984	0.00267	CcSEcCtD
Rifaximin—Arthralgia—Temozolomide—brain cancer	0.000984	0.00267	CcSEcCtD
Rifaximin—Rash—Procarbazine—brain cancer	0.000984	0.00267	CcSEcCtD
Rifaximin—Dermatitis—Procarbazine—brain cancer	0.000983	0.00267	CcSEcCtD
Rifaximin—Headache—Procarbazine—brain cancer	0.000978	0.00265	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000978	0.00265	CcSEcCtD
Rifaximin—Discomfort—Temozolomide—brain cancer	0.000973	0.00264	CcSEcCtD
Rifaximin—Infection—Carmustine—brain cancer	0.00097	0.00263	CcSEcCtD
Rifaximin—Angiopathy—Etoposide—brain cancer	0.000964	0.00262	CcSEcCtD
Rifaximin—Dry mouth—Temozolomide—brain cancer	0.000963	0.00261	CcSEcCtD
Rifaximin—Mediastinal disorder—Etoposide—brain cancer	0.000958	0.0026	CcSEcCtD
Rifaximin—Body temperature increased—Hydroxyurea—brain cancer	0.000955	0.00259	CcSEcCtD
Rifaximin—Confusional state—Temozolomide—brain cancer	0.000952	0.00258	CcSEcCtD
Rifaximin—Anaphylactic shock—Temozolomide—brain cancer	0.000944	0.00256	CcSEcCtD
Rifaximin—Infection—Temozolomide—brain cancer	0.000938	0.00254	CcSEcCtD
Rifaximin—Anorexia—Carmustine—brain cancer	0.000931	0.00253	CcSEcCtD
Rifaximin—Nausea—Procarbazine—brain cancer	0.000927	0.00252	CcSEcCtD
Rifaximin—Nervous system disorder—Temozolomide—brain cancer	0.000925	0.00251	CcSEcCtD
Rifaximin—Skin disorder—Temozolomide—brain cancer	0.000917	0.00249	CcSEcCtD
Rifaximin—Hypotension—Carmustine—brain cancer	0.000913	0.00248	CcSEcCtD
Rifaximin—Hyperhidrosis—Temozolomide—brain cancer	0.000912	0.00248	CcSEcCtD
Rifaximin—Anorexia—Temozolomide—brain cancer	0.0009	0.00244	CcSEcCtD
Rifaximin—Back pain—Etoposide—brain cancer	0.000895	0.00243	CcSEcCtD
Rifaximin—Hypersensitivity—Hydroxyurea—brain cancer	0.00089	0.00242	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Carmustine—brain cancer	0.00089	0.00241	CcSEcCtD
Rifaximin—Muscle spasms—Etoposide—brain cancer	0.00089	0.00241	CcSEcCtD
Rifaximin—Insomnia—Carmustine—brain cancer	0.000883	0.0024	CcSEcCtD
Rifaximin—Dyspnoea—Carmustine—brain cancer	0.000871	0.00236	CcSEcCtD
Rifaximin—Asthenia—Hydroxyurea—brain cancer	0.000867	0.00235	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00086	0.00233	CcSEcCtD
Rifaximin—Ill-defined disorder—Etoposide—brain cancer	0.000859	0.00233	CcSEcCtD
Rifaximin—Anaemia—Etoposide—brain cancer	0.000855	0.00232	CcSEcCtD
Rifaximin—Insomnia—Temozolomide—brain cancer	0.000854	0.00232	CcSEcCtD
Rifaximin—Decreased appetite—Carmustine—brain cancer	0.000849	0.0023	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Carmustine—brain cancer	0.000843	0.00229	CcSEcCtD
Rifaximin—Dyspnoea—Temozolomide—brain cancer	0.000841	0.00228	CcSEcCtD
Rifaximin—Pain—Carmustine—brain cancer	0.000835	0.00227	CcSEcCtD
Rifaximin—Constipation—Carmustine—brain cancer	0.000835	0.00227	CcSEcCtD
Rifaximin—Malaise—Etoposide—brain cancer	0.000834	0.00226	CcSEcCtD
Rifaximin—Vertigo—Etoposide—brain cancer	0.000831	0.00226	CcSEcCtD
Rifaximin—Diarrhoea—Hydroxyurea—brain cancer	0.000827	0.00224	CcSEcCtD
Rifaximin—Decreased appetite—Temozolomide—brain cancer	0.00082	0.00223	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Temozolomide—brain cancer	0.000815	0.00221	CcSEcCtD
Rifaximin—Fatigue—Temozolomide—brain cancer	0.000814	0.00221	CcSEcCtD
Rifaximin—Loss of consciousness—Etoposide—brain cancer	0.000813	0.00221	CcSEcCtD
Rifaximin—Cough—Etoposide—brain cancer	0.000807	0.00219	CcSEcCtD
Rifaximin—Pain—Temozolomide—brain cancer	0.000807	0.00219	CcSEcCtD
Rifaximin—Constipation—Temozolomide—brain cancer	0.000807	0.00219	CcSEcCtD
Rifaximin—Feeling abnormal—Carmustine—brain cancer	0.000805	0.00218	CcSEcCtD
Rifaximin—Dizziness—Hydroxyurea—brain cancer	0.000799	0.00217	CcSEcCtD
Rifaximin—Gastrointestinal pain—Carmustine—brain cancer	0.000799	0.00217	CcSEcCtD
Rifaximin—Chest pain—Etoposide—brain cancer	0.000788	0.00214	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000782	0.00212	CcSEcCtD
Rifaximin—Discomfort—Etoposide—brain cancer	0.000778	0.00211	CcSEcCtD
Rifaximin—Feeling abnormal—Temozolomide—brain cancer	0.000778	0.00211	CcSEcCtD
Rifaximin—Body temperature increased—Carmustine—brain cancer	0.000772	0.0021	CcSEcCtD
Rifaximin—Abdominal pain—Carmustine—brain cancer	0.000772	0.0021	CcSEcCtD
Rifaximin—Gastrointestinal pain—Temozolomide—brain cancer	0.000772	0.00209	CcSEcCtD
Rifaximin—Vomiting—Hydroxyurea—brain cancer	0.000768	0.00208	CcSEcCtD
Rifaximin—Rash—Hydroxyurea—brain cancer	0.000762	0.00207	CcSEcCtD
Rifaximin—Confusional state—Etoposide—brain cancer	0.000761	0.00207	CcSEcCtD
Rifaximin—Dermatitis—Hydroxyurea—brain cancer	0.000761	0.00207	CcSEcCtD
Rifaximin—Headache—Hydroxyurea—brain cancer	0.000757	0.00205	CcSEcCtD
Rifaximin—Anaphylactic shock—Etoposide—brain cancer	0.000755	0.00205	CcSEcCtD
Rifaximin—Infection—Etoposide—brain cancer	0.00075	0.00204	CcSEcCtD
Rifaximin—Urticaria—Temozolomide—brain cancer	0.00075	0.00203	CcSEcCtD
Rifaximin—Abdominal pain—Temozolomide—brain cancer	0.000746	0.00202	CcSEcCtD
Rifaximin—Body temperature increased—Temozolomide—brain cancer	0.000746	0.00202	CcSEcCtD
Rifaximin—Skin disorder—Etoposide—brain cancer	0.000733	0.00199	CcSEcCtD
Rifaximin—Hyperhidrosis—Etoposide—brain cancer	0.00073	0.00198	CcSEcCtD
Rifaximin—Anorexia—Etoposide—brain cancer	0.00072	0.00195	CcSEcCtD
Rifaximin—Hypersensitivity—Carmustine—brain cancer	0.000719	0.00195	CcSEcCtD
Rifaximin—Nausea—Hydroxyurea—brain cancer	0.000718	0.00195	CcSEcCtD
Rifaximin—Hypotension—Etoposide—brain cancer	0.000706	0.00192	CcSEcCtD
Rifaximin—Asthenia—Carmustine—brain cancer	0.000701	0.0019	CcSEcCtD
Rifaximin—Hypersensitivity—Temozolomide—brain cancer	0.000695	0.00189	CcSEcCtD
Rifaximin—Asthenia—Temozolomide—brain cancer	0.000677	0.00184	CcSEcCtD
Rifaximin—Dyspnoea—Etoposide—brain cancer	0.000673	0.00183	CcSEcCtD
Rifaximin—Diarrhoea—Carmustine—brain cancer	0.000668	0.00181	CcSEcCtD
Rifaximin—Pruritus—Temozolomide—brain cancer	0.000668	0.00181	CcSEcCtD
Rifaximin—Decreased appetite—Etoposide—brain cancer	0.000656	0.00178	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Etoposide—brain cancer	0.000652	0.00177	CcSEcCtD
Rifaximin—Fatigue—Etoposide—brain cancer	0.000651	0.00177	CcSEcCtD
Rifaximin—Dizziness—Carmustine—brain cancer	0.000646	0.00175	CcSEcCtD
Rifaximin—Pain—Etoposide—brain cancer	0.000646	0.00175	CcSEcCtD
Rifaximin—Constipation—Etoposide—brain cancer	0.000646	0.00175	CcSEcCtD
Rifaximin—Diarrhoea—Temozolomide—brain cancer	0.000646	0.00175	CcSEcCtD
Rifaximin—Dizziness—Temozolomide—brain cancer	0.000624	0.00169	CcSEcCtD
Rifaximin—Feeling abnormal—Etoposide—brain cancer	0.000622	0.00169	CcSEcCtD
Rifaximin—Vomiting—Carmustine—brain cancer	0.000621	0.00169	CcSEcCtD
Rifaximin—Gastrointestinal pain—Etoposide—brain cancer	0.000618	0.00168	CcSEcCtD
Rifaximin—Rash—Carmustine—brain cancer	0.000616	0.00167	CcSEcCtD
Rifaximin—Dermatitis—Carmustine—brain cancer	0.000615	0.00167	CcSEcCtD
Rifaximin—Headache—Carmustine—brain cancer	0.000612	0.00166	CcSEcCtD
Rifaximin—Vomiting—Temozolomide—brain cancer	0.0006	0.00163	CcSEcCtD
Rifaximin—Urticaria—Etoposide—brain cancer	0.0006	0.00163	CcSEcCtD
Rifaximin—Body temperature increased—Etoposide—brain cancer	0.000597	0.00162	CcSEcCtD
Rifaximin—Abdominal pain—Etoposide—brain cancer	0.000597	0.00162	CcSEcCtD
Rifaximin—Rash—Temozolomide—brain cancer	0.000595	0.00161	CcSEcCtD
Rifaximin—Dermatitis—Temozolomide—brain cancer	0.000594	0.00161	CcSEcCtD
Rifaximin—Headache—Temozolomide—brain cancer	0.000591	0.0016	CcSEcCtD
Rifaximin—Nausea—Carmustine—brain cancer	0.00058	0.00157	CcSEcCtD
Rifaximin—Nausea—Temozolomide—brain cancer	0.000561	0.00152	CcSEcCtD
Rifaximin—Hypersensitivity—Etoposide—brain cancer	0.000556	0.00151	CcSEcCtD
Rifaximin—Asthenia—Etoposide—brain cancer	0.000542	0.00147	CcSEcCtD
Rifaximin—Pruritus—Etoposide—brain cancer	0.000534	0.00145	CcSEcCtD
Rifaximin—Diarrhoea—Etoposide—brain cancer	0.000517	0.0014	CcSEcCtD
Rifaximin—Dizziness—Etoposide—brain cancer	0.000499	0.00136	CcSEcCtD
Rifaximin—Vomiting—Etoposide—brain cancer	0.00048	0.0013	CcSEcCtD
Rifaximin—Rash—Etoposide—brain cancer	0.000476	0.00129	CcSEcCtD
Rifaximin—Dermatitis—Etoposide—brain cancer	0.000476	0.00129	CcSEcCtD
Rifaximin—Headache—Etoposide—brain cancer	0.000473	0.00128	CcSEcCtD
Rifaximin—Nausea—Etoposide—brain cancer	0.000449	0.00122	CcSEcCtD
